Cardiovascular disease is the leading cause of death and disability in older Americans. Results of studies in experimental animals have shown that with senescence there is a decline in myocardial fatty acid utilization (MFAU) and oxidation (MFAO) and a relative increase in glucose utilization (MGU). These metabolic changes are paralleled by a decline in mechanical function. During the current grant interval, we have confirmed these observations in humans. The goal of this renewal application is to identify potential mechanisms responsible for the age-related shift in myocardial substrate metabolism and relate them to changes in left ventricular (LV) function. The nitric oxide (NO) system and the peroxisome proliferator activated receptor alpha (PPAR alpha) are promising candidates that will be investigated. Our first hypothesis is that changes in substrate utilization in the aging heart are mediated, at least in part, by a decline NO production and that these changes are paralleled by a decline in LV function. We will prove or disprove this hypothesis by performing a series of fairly-complex experiments that utilize PET quantification of myocardial substrate metabolism and echocardiographic measurements of LV systolic anddiast01ic function under conditions designed to reduce NO production in younger subjects (using L-NMMA) and increase NO production in older subjects (using L-arginine). Our second hypothesis is that changes in myocardial substrate metabolism and LV function in the aging heart may be mediated, at least in part, via a decline in PPAR alpha-mediated responses. Thus, administration of a PPAR alpha agonist to older humans will result in an increase in MFAO and MFAU and a decline in MGU and that this metabolic shift will be paralleled by an improvement in LV function. Using the same imaging techniques we will measure myocardial substrate metabolism and function before and after the administration of the PPAR alpha partial agonist, gemfibrozil to healthy older subjects to prove or disprove this hypothesis. The results of these studies should further our understanding of the role of NO and PPAR alpha in modulating this age-dependent myocardial metabolic shift and its impact on LV function. As a result, potentially new targets could be identified for novel therapeutics designed to treat various cardiac disorders that increase with age and potentially slow the impact of aging on the human heart.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG015466-09
Application #
7090724
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Rossi, Winifred K
Project Start
1998-05-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
9
Fiscal Year
2006
Total Cost
$712,310
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
McGill, Janet B; Peterson, Linda R; Herrero, Pilar et al. (2011) Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance. J Nucl Cardiol 18:421-9; quiz 432-3
Peterson, Linda R; Soto, Pablo F; Herrero, Pilar et al. (2008) Impact of gender on the myocardial metabolic response to obesity. JACC Cardiovasc Imaging 1:424-33
Gropler, Robert J (2008) Molecular imaging will replace myocardial perfusion imaging. J Nucl Cardiol 15:429-34
Saeed, Ibrahim M; Barry, Michael; Peterson, Linda R et al. (2007) Positron emission tomography imaging in the cardiometabolic syndrome. J Cardiometab Syndr 2:67-9
Peterson, Linda R; Soto, Pablo F; Herrero, Pilar et al. (2007) Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 14:573-81
de las Fuentes, Lisa; Brown, Angela L; Mathews, Santhosh J et al. (2007) Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 28:553-9
Cresci, Sharon; Gropler, Robert J (2007) Image-guided cardiovascular functional genomics: finding the needle in the haystack. J Nucl Cardiol 14:275-6
de las Fuentes, Lisa; Soto, Pablo F; Cupps, Brian P et al. (2006) Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency. J Nucl Cardiol 13:369-77
Herrero, Pilar; Peterson, Linda R; McGill, Janet B et al. (2006) Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 47:598-604
Srinivasan, Muthayyah; Herrero, Pilar; McGill, Janet B et al. (2005) The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 46:42-8

Showing the most recent 10 out of 17 publications